Concepts (150)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Inflammatory Bowel Diseases | 11 | 2021 | 3209 | 1.35 | Why? |
| Colitis, Ulcerative | 5 | 2020 | 1037 | 1.04 | Why? |
| Crohn Disease | 5 | 2020 | 959 | 0.99 | Why? |
| Ileitis | 2 | 2019 | 21 | 0.88 | Why? |
| Endoscopy | 3 | 2020 | 1564 | 0.87 | Why? |
| Laxatives | 1 | 2017 | 18 | 0.71 | Why? |
| Cathartics | 1 | 2017 | 41 | 0.70 | Why? |
| Rectal Fistula | 1 | 2017 | 38 | 0.67 | Why? |
| Anus Diseases | 1 | 2017 | 55 | 0.66 | Why? |
| Budesonide | 2 | 2018 | 192 | 0.64 | Why? |
| Therapeutic Irrigation | 1 | 2017 | 167 | 0.63 | Why? |
| Hospital Units | 2 | 2020 | 1017 | 0.63 | Why? |
| Abscess | 1 | 2017 | 234 | 0.55 | Why? |
| Anal Canal | 1 | 2017 | 367 | 0.53 | Why? |
| Standard of Care | 1 | 2020 | 1297 | 0.51 | Why? |
| Colon | 1 | 2017 | 669 | 0.47 | Why? |
| Hypnotics and Sedatives | 1 | 2017 | 624 | 0.46 | Why? |
| Colonoscopy | 1 | 2017 | 738 | 0.43 | Why? |
| Gastroenterology | 2 | 2020 | 1352 | 0.40 | Why? |
| Intestinal Mucosa | 1 | 2017 | 1046 | 0.39 | Why? |
| Biological Therapy | 2 | 2021 | 456 | 0.31 | Why? |
| Communicable Diseases | 1 | 2020 | 2148 | 0.29 | Why? |
| Anti-Inflammatory Agents | 3 | 2018 | 6153 | 0.27 | Why? |
| Gastrointestinal Agents | 2 | 2020 | 393 | 0.27 | Why? |
| Infection Control | 3 | 2020 | 23131 | 0.25 | Why? |
| Ultrasonography | 1 | 2017 | 4409 | 0.21 | Why? |
| Colitis | 2 | 2021 | 266 | 0.20 | Why? |
| Biological Availability | 2 | 2018 | 388 | 0.20 | Why? |
| Intestinal Fistula | 1 | 2019 | 43 | 0.20 | Why? |
| Italy | 12 | 2021 | 38444 | 0.19 | Why? |
| Facility Design and Construction | 1 | 2020 | 189 | 0.18 | Why? |
| Professional Practice Gaps | 1 | 2018 | 41 | 0.18 | Why? |
| Hospital Planning | 1 | 2020 | 238 | 0.17 | Why? |
| Mesalamine | 1 | 2018 | 89 | 0.17 | Why? |
| Patient Care Management | 2 | 2020 | 1514 | 0.17 | Why? |
| Biological Factors | 1 | 2021 | 276 | 0.17 | Why? |
| Anticarcinogenic Agents | 1 | 2017 | 25 | 0.17 | Why? |
| Delayed-Action Preparations | 1 | 2018 | 291 | 0.15 | Why? |
| B-Lymphocyte Subsets | 1 | 2017 | 372 | 0.15 | Why? |
| Infliximab | 1 | 2020 | 502 | 0.15 | Why? |
| Staff Development | 1 | 2018 | 222 | 0.14 | Why? |
| Professional Practice | 1 | 2018 | 322 | 0.14 | Why? |
| Administration, Oral | 2 | 2018 | 2340 | 0.13 | Why? |
| Quarantine | 1 | 2020 | 18418 | 0.12 | Why? |
| Diffusion of Innovation | 1 | 2017 | 440 | 0.12 | Why? |
| Predictive Value of Tests | 2 | 2017 | 9537 | 0.11 | Why? |
| Equipment Contamination | 1 | 2020 | 1308 | 0.11 | Why? |
| Coronavirus | 1 | 2020 | 18339 | 0.11 | Why? |
| Immunomodulation | 1 | 2020 | 1472 | 0.11 | Why? |
| Pandemics | 9 | 2020 | 389249 | 0.11 | Why? |
| Critical Pathways | 1 | 2020 | 1587 | 0.10 | Why? |
| Pneumonia, Viral | 5 | 2020 | 243684 | 0.10 | Why? |
| Demography | 1 | 2017 | 1660 | 0.10 | Why? |
| Coronavirus Infections | 5 | 2020 | 253789 | 0.10 | Why? |
| Practice Patterns, Physicians' | 2 | 2018 | 4927 | 0.09 | Why? |
| Gastrointestinal Diseases | 2 | 2021 | 2580 | 0.09 | Why? |
| Humans | 23 | 2021 | 930598 | 0.09 | Why? |
| Drug Delivery Systems | 1 | 2018 | 1365 | 0.09 | Why? |
| Needs Assessment | 1 | 2018 | 2352 | 0.09 | Why? |
| Public Health Surveillance | 1 | 2020 | 3129 | 0.08 | Why? |
| Evidence-Based Medicine | 2 | 2017 | 3228 | 0.08 | Why? |
| Colorectal Neoplasms | 2 | 2019 | 1884 | 0.08 | Why? |
| New York City | 1 | 2020 | 7432 | 0.08 | Why? |
| Prognosis | 3 | 2021 | 32490 | 0.07 | Why? |
| Patient Safety | 1 | 2020 | 4885 | 0.07 | Why? |
| Immunotherapy | 1 | 2017 | 2421 | 0.07 | Why? |
| Adrenal Cortex Hormones | 2 | 2017 | 6537 | 0.06 | Why? |
| B-Lymphocytes | 1 | 2017 | 4418 | 0.06 | Why? |
| Betacoronavirus | 4 | 2020 | 204454 | 0.06 | Why? |
| Forecasting | 1 | 2017 | 4492 | 0.06 | Why? |
| Disease Management | 1 | 2020 | 6841 | 0.06 | Why? |
| Diagnosis, Differential | 1 | 2017 | 7220 | 0.06 | Why? |
| Severity of Illness Index | 3 | 2018 | 48226 | 0.05 | Why? |
| Mass Screening | 1 | 2020 | 8005 | 0.05 | Why? |
| Late Onset Disorders | 1 | 2019 | 30 | 0.05 | Why? |
| Magnetic Resonance Imaging | 1 | 2017 | 6551 | 0.05 | Why? |
| T-Lymphocytes | 1 | 2017 | 6670 | 0.05 | Why? |
| Quality of Life | 1 | 2020 | 9820 | 0.05 | Why? |
| Constriction, Pathologic | 1 | 2019 | 212 | 0.05 | Why? |
| Prospective Studies | 3 | 2021 | 43301 | 0.05 | Why? |
| CD27 Ligand | 1 | 2017 | 17 | 0.05 | Why? |
| Surveys and Questionnaires | 3 | 2020 | 43792 | 0.05 | Why? |
| Antibodies, Monoclonal | 1 | 2017 | 8041 | 0.04 | Why? |
| Aminosalicylic Acid | 1 | 2017 | 8 | 0.04 | Why? |
| Nausea | 1 | 2021 | 457 | 0.04 | Why? |
| Beclomethasone | 1 | 2017 | 32 | 0.04 | Why? |
| Tumor Necrosis Factor-alpha | 2 | 2017 | 2483 | 0.04 | Why? |
| Mercaptopurine | 1 | 2017 | 68 | 0.04 | Why? |
| Polypharmacy | 1 | 2019 | 347 | 0.04 | Why? |
| Vomiting | 1 | 2021 | 722 | 0.04 | Why? |
| Hospitalization | 3 | 2020 | 54280 | 0.04 | Why? |
| Middle Aged | 8 | 2021 | 270681 | 0.04 | Why? |
| Adult | 7 | 2021 | 244371 | 0.03 | Why? |
| Homeostasis | 1 | 2017 | 582 | 0.03 | Why? |
| Administration, Intravenous | 1 | 2017 | 1115 | 0.03 | Why? |
| United States | 1 | 2020 | 46150 | 0.03 | Why? |
| Prednisone | 1 | 2017 | 652 | 0.03 | Why? |
| Cyclosporine | 1 | 2017 | 449 | 0.03 | Why? |
| Patient Acuity | 1 | 2020 | 1755 | 0.03 | Why? |
| Immunophenotyping | 1 | 2017 | 1290 | 0.03 | Why? |
| Methotrexate | 1 | 2017 | 471 | 0.03 | Why? |
| Digestive System Surgical Procedures | 1 | 2019 | 677 | 0.03 | Why? |
| Calcium | 1 | 2017 | 708 | 0.03 | Why? |
| Female | 8 | 2021 | 380317 | 0.03 | Why? |
| Neoplasms | 1 | 2020 | 17251 | 0.03 | Why? |
| Male | 7 | 2021 | 367725 | 0.03 | Why? |
| Aftercare | 1 | 2020 | 1637 | 0.03 | Why? |
| Drug Administration Schedule | 1 | 2017 | 2324 | 0.03 | Why? |
| Organizational Innovation | 1 | 2020 | 2468 | 0.03 | Why? |
| Immunosuppressive Agents | 2 | 2020 | 6331 | 0.03 | Why? |
| Tomography, X-Ray Computed | 1 | 2017 | 25144 | 0.03 | Why? |
| Telemedicine | 1 | 2020 | 25032 | 0.02 | Why? |
| Flow Cytometry | 1 | 2017 | 2393 | 0.02 | Why? |
| Diarrhea | 1 | 2021 | 2743 | 0.02 | Why? |
| Prevalence | 2 | 2021 | 25773 | 0.02 | Why? |
| Health Care Surveys | 1 | 2017 | 2942 | 0.02 | Why? |
| Recurrence | 1 | 2017 | 3675 | 0.02 | Why? |
| Risk Factors | 3 | 2020 | 71621 | 0.02 | Why? |
| Logistic Models | 1 | 2021 | 9089 | 0.02 | Why? |
| Remote Consultation | 1 | 2020 | 2396 | 0.02 | Why? |
| Quality Improvement | 1 | 2018 | 2435 | 0.02 | Why? |
| Dietary Supplements | 1 | 2017 | 2251 | 0.02 | Why? |
| Adolescent | 3 | 2021 | 86841 | 0.02 | Why? |
| Retrospective Studies | 3 | 2021 | 105322 | 0.02 | Why? |
| Young Adult | 3 | 2021 | 93724 | 0.02 | Why? |
| Glucocorticoids | 1 | 2019 | 4431 | 0.02 | Why? |
| Immunologic Factors | 1 | 2019 | 4206 | 0.02 | Why? |
| Drug Therapy, Combination | 1 | 2017 | 7268 | 0.02 | Why? |
| Biological Products | 1 | 2017 | 2331 | 0.01 | Why? |
| Vitamin D | 1 | 2017 | 2904 | 0.01 | Why? |
| Case-Control Studies | 1 | 2020 | 17671 | 0.01 | Why? |
| Attitude of Health Personnel | 1 | 2018 | 4741 | 0.01 | Why? |
| Treatment Outcome | 2 | 2017 | 51732 | 0.01 | Why? |
| Infant, Newborn | 1 | 2021 | 23105 | 0.01 | Why? |
| Aged | 3 | 2021 | 215776 | 0.01 | Why? |
| Incidence | 1 | 2021 | 25622 | 0.01 | Why? |
| Age Factors | 1 | 2020 | 21039 | 0.01 | Why? |
| Infant | 1 | 2021 | 30274 | 0.01 | Why? |
| Randomized Controlled Trials as Topic | 1 | 2017 | 10649 | 0.01 | Why? |
| Time Factors | 1 | 2021 | 31397 | 0.01 | Why? |
| Child, Preschool | 1 | 2021 | 36283 | 0.01 | Why? |
| Cohort Studies | 1 | 2019 | 36005 | 0.01 | Why? |
| Comorbidity | 1 | 2020 | 34796 | 0.01 | Why? |
| Antibodies, Monoclonal, Humanized | 1 | 2017 | 9335 | 0.01 | Why? |
| Anti-Bacterial Agents | 1 | 2017 | 10083 | 0.01 | Why? |
| Pregnancy | 1 | 2017 | 23879 | 0.01 | Why? |
| Child | 1 | 2021 | 70012 | 0.01 | Why? |
| Disease Outbreaks | 1 | 2020 | 27595 | 0.01 | Why? |
| Aged, 80 and over | 1 | 2021 | 88759 | 0.01 | Why? |
| Animals | 1 | 2017 | 78931 | 0.01 | Why? |
Saibeni's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(150)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(113)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_